Today, our Managing Director Dr. Dieter Runge has been invited to the Taiwan-Germany Conference on Healthcare Applications, organized by the German Trade Office Taipei — DEinternational Taiwan Ltd., where we joined leading German biopharmaceutical and medtech companies to explore the application and collaboration opportunities of precision medicine, drug development, and innovative technologies in the Taiwanese market.

Highlights
-
German Biopharmaceutical Innovation: The conference showcased Germany’s latest achievements in drug development, regulatory support, in vitro Technologies, medical‑grade coatings, and precision packaging.
-
Opportunities for Bilateral Cooperation: Against the backdrop of Taiwan’s rapidly aging population and healthcare workforce shortages, deep collaboration between German companies and local Taiwanese healthcare institutions is driving sustainable development of medical services and technologies.
Key Strengths of Primacyt Cell Culture Technology GmbH
-
🔬Liver Cell Organoid & In Vitro Testing Platform: Primacyt offers industry-leading liver-related cell culture products and medical device testing services, providing efficient and reliable solutions for drug safety assessment and toxicological research.
-
🤝Supporting Taiwan’s Pharma & Biotech: Our technologies can significantly shorten preclinical development timelines and reduce reliance on animal testing, helping Taiwanese pharmaceutical companies achieve breakthroughs in precision and personalized medicine.
-
🌱Commitment to Sustainability: Guided by our mission to reduce animal testing and promote humane research, Primacyt is dedicated to advancing more environmentally friendly and efficient life-science research models.